Cidara Therapeutics Stock Forecast - Naive Prediction

CDTX Stock  USD 20.21  0.01  0.05%   
The Naive Prediction forecasted value of Cidara Therapeutics on the next trading day is expected to be 22.69 with a mean absolute deviation of 0.39 and the sum of the absolute errors of 24.13. Cidara Stock Forecast is based on your current time horizon.
  
At this time, Cidara Therapeutics' Inventory Turnover is fairly stable compared to the past year. Fixed Asset Turnover is likely to rise to 15.54 in 2024, whereas Payables Turnover is likely to drop 0.38 in 2024. . Common Stock Shares Outstanding is likely to rise to about 4.6 M in 2024, whereas Net Loss is likely to drop (28.2 M) in 2024.
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Cidara Therapeutics' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2013-12-31
Previous Quarter
164.4 M
Current Value
127.4 M
Quarterly Volatility
31.8 M
 
Yuan Drop
 
Covid
A naive forecasting model for Cidara Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Cidara Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Cidara Therapeutics Naive Prediction Price Forecast For the 1st of December

Given 90 days horizon, the Naive Prediction forecasted value of Cidara Therapeutics on the next trading day is expected to be 22.69 with a mean absolute deviation of 0.39, mean absolute percentage error of 0.34, and the sum of the absolute errors of 24.13.
Please note that although there have been many attempts to predict Cidara Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cidara Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Cidara Therapeutics Stock Forecast Pattern

Backtest Cidara TherapeuticsCidara Therapeutics Price PredictionBuy or Sell Advice 

Cidara Therapeutics Forecasted Value

In the context of forecasting Cidara Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cidara Therapeutics' downside and upside margins for the forecasting period are 18.49 and 26.89, respectively. We have considered Cidara Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
20.21
22.69
Expected Value
26.89
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Cidara Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Cidara Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.884
BiasArithmetic mean of the errors None
MADMean absolute deviation0.3891
MAPEMean absolute percentage error0.028
SAESum of the absolute errors24.127
This model is not at all useful as a medium-long range forecasting tool of Cidara Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Cidara Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Cidara Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cidara Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cidara Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
16.3720.5724.77
Details
Intrinsic
Valuation
LowRealHigh
9.1213.3222.22
Details
4 Analysts
Consensus
LowTargetHigh
5.105.606.22
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-6.84-6.27-5.67
Details

Other Forecasting Options for Cidara Therapeutics

For every potential investor in Cidara, whether a beginner or expert, Cidara Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cidara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cidara. Basic forecasting techniques help filter out the noise by identifying Cidara Therapeutics' price trends.

Cidara Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cidara Therapeutics stock to make a market-neutral strategy. Peer analysis of Cidara Therapeutics could also be used in its relative valuation, which is a method of valuing Cidara Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Cidara Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cidara Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cidara Therapeutics' current price.

Cidara Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Cidara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cidara Therapeutics shares will generate the highest return on investment. By undertsting and applying Cidara Therapeutics stock market strength indicators, traders can identify Cidara Therapeutics entry and exit signals to maximize returns.

Cidara Therapeutics Risk Indicators

The analysis of Cidara Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cidara Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cidara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cidara Stock Analysis

When running Cidara Therapeutics' price analysis, check to measure Cidara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cidara Therapeutics is operating at the current time. Most of Cidara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cidara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cidara Therapeutics' price. Additionally, you may evaluate how the addition of Cidara Therapeutics to your portfolios can decrease your overall portfolio volatility.